Company Profile

Immutep Limited (NASDAQ: IMMP)
5:00 PM UTC, 07/03/24
Last: $1.98 Change: +0.10 %Change: +5.32% Volume: 92,052
Detailed Quote
Open: $ 1.95   Volume: 92,052
High: $ 2.04   Yield(%) 0.00
Low: $ 1.91   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 237.47M
EPS ($) n/a   Shares Out: 126.31M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -37.44
% Price Change (last 13 weeks): -25.98
% Price Change (last 26 weeks): -20.00
% Price Change (last 52 weeks): -12.96
% Price Change (year to date): -21.67
Management Effectiveness
Return on Equity (%): -34.51
Return on Assets (%): -31.87
Return on Invested Capital (%): -39.77
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): 0.00
Price & Volume
50-day Moving Average: $2.65
200-day Moving Average: $2.30
Avg. Daily Vol. (last 50 days): 341,798
Avg. Daily Vol. (last 200 days): 199,665
52-wk high: $3.33
52-wk low: $1.58
Bid: $1.93
Ask: $2.01
Company Information
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987, and is headquartered in Sydney, Australia.
Immutep Limited
Australia Square 264 George Street Level 32, Suite 32.07
Sydney NS 2000

Phone: 61.2.8315.7003
Fax: 61.2.8569.1880
http://www.immutep.com
Per Share Data
Earnings (1year) ($): -0.26
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 0.76
Cash Flow ($): -0.21
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): 2.78
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 13.81
Current Ratio (x): 13.81
LT Debt/Equity (x): 0.76
Total Debt/Equity (x): 0.90



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.